DCF — SHANDS JACKSONVILLE MEDICAL CENTER
Enterprise Value: $-1.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.0B
Enterprise Value
$-328.7M
PV of Cash Flows
$-683.4M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $887.3M | $-58.4M | -7.0% | $-95.9M | $-87.2M |
| Year 2 | $913.9M | $-51.0M | -6.0% | $-89.7M | $-74.1M |
| Year 3 | $941.3M | $-43.1M | -5.0% | $-83.0M | $-62.3M |
| Year 4 | $969.6M | $-39.6M | -4.0% | $-80.6M | $-55.1M |
| Year 5 | $998.7M | $-38.3M | -4.0% | $-80.5M | $-50.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$861.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07080739701380788
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5